<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34818320</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>47</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Enterovirus D68-Associated Acute Respiratory Illness ─ New Vaccine Surveillance Network, United States, July-November 2018-2020.</ArticleTitle><Pagination><StartPage>1623</StartPage><EndPage>1628</EndPage><MedlinePgn>1623-1628</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7047a1</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is associated with a broad spectrum of illnesses, including mild to severe acute respiratory illness (ARI) and acute flaccid myelitis (AFM). Enteroviruses, including EV-D68, are typically detected in the United States during late summer through fall, with year-to-year fluctuations. Before 2014, EV-D68 was infrequently reported to CDC (1). However, numbers of EV-D68 detection have increased in recent years, with a biennial pattern observed during 2014-2018 in the United States, after the expansion of surveillance and wider availability of molecular testing. In 2014, a national outbreak of EV-D68 was detected (2). EV-D68 was also reported in 2016 via local (3) and passive national (4) surveillance. EV-D68 detections were limited in 2017, but substantial circulation was observed in 2018 (5). To assess recent levels of circulation, EV-D68 detections in respiratory specimens collected from patients aged &lt;18 years* with ARI evaluated in emergency departments (EDs) or admitted to one of seven U.S. medical centers<sup>†</sup> within the New Vaccine Surveillance Network (NVSN) were summarized. This report provides a provisional description of EV-D68 detections during July-November in 2018, 2019 and 2020, and describes the demographic and clinical characteristics of these patients. In 2018, a total of 382 EV-D68 detections in respiratory specimens obtained from patients aged &lt;18 years with ARI were reported by NVSN; the number decreased to six detections in 2019 and 30 in 2020. Among patients aged &lt;18 years with EV-D68 in 2020, 22 (73%) were non-Hispanic Black (Black) persons. EV-D68 detections in 2020 were lower than anticipated based on the biennial circulation pattern observed since 2014. The circulation of EV-D68 in 2020 might have been limited by widespread COVID-19 mitigation measures; how these changes in behavior might influence the timing and levels of circulation in future years is unknown. Ongoing monitoring of EV-D68 detections is warranted for preparedness for EV-D68-associated ARI and AFM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Melisa M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Ariana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lively</LastName><ForeName>Joana Y</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Avadhanula</LastName><ForeName>Vasanthi</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Boom</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Chappell</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Fregoe</LastName><ForeName>Wende</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Halasa</LastName><ForeName>Natasha B</ForeName><Initials>NB</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Hickey</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Eileen J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>McNeal</LastName><ForeName>Monica M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Michaels</LastName><ForeName>Marian G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Moffatt</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Otten</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sahni</LastName><ForeName>Leila C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Schlaudecker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Schuster</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Selvarangan</LastName><ForeName>Rangaraj</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Staat</LastName><ForeName>Mary A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Laura S</ForeName><Initials>LS</Initials></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Geoffrey A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>John V</ForeName><Initials>JV</Initials></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Terry Fan Fei</ForeName><Initials>TFF</Initials></Author><Author ValidYN="Y"><LastName>Routh</LastName><ForeName>Janell A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Gerber</LastName><ForeName>Susan I</ForeName><Initials>SI</Initials></Author><Author ValidYN="Y"><LastName>McMorrow</LastName><ForeName>Meredith L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Rha</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Midgley</LastName><ForeName>Claire M</ForeName><Initials>CM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 IP001158</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001050</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001157</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001049</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001063</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="N">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Janet A. Englund reports institutional research support from AstraZeneca, Merck &amp; Co., Pfizer Inc., and GlaxoSmithKline plc; consulting fees from Sanofi Pasteur, Meissa Vaccines Incorporated, AstraZeneca, and Teva Pharmaceutical Industries Ltd.; and unpaid membership on the publication committees for the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society. Christopher J. Harrison reports institutional grant support from GlaxoSmithKline plc and Pfizer Inc., for vaccine studies and from Merck &amp; Co. for a study of antibiotic resistance, and royalties from UpToDate for editing chapter on rotavirus. Natasha B. Halasa reports institutional support from Sanofi Pasteur and Quidel Corporation. Geoffrey A. Weinberg reports honoraria as a consultant to ReViral Ltd, and as an author of textbook chapters in the Merck Manual. No other potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>24</Day><Hour>17</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34818320</ArticleId><ArticleId IdType="pmc">PMC8612514</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7047a1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA; CDC. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ 2006;55:1–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, et al.; EV-D68 Working Group. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 2015;3:879–87. 10.1016/S2213-2600(15)00335-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Robinson CC, Pretty K, Yuan J, Dominguez SR. Surveillance for enterovirus D68 in Colorado children reveals continued circulation. J Clin Virol 2017;92:39–41. 10.1016/j.jcv.2017.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.009</ArticleId><ArticleId IdType="pmc">PMC5625344</ArticleId><ArticleId IdType="pubmed">28521212</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Nix WA, Oberste MS, Gerber SI. Enterovirus and parechovirus surveillance—United States, 2014–2016. MMWR Morb Mortal Wkly Rep 2018;67:515–8. 10.15585/mmwr.mm6718a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6718a2</ArticleId><ArticleId IdType="pmc">PMC5944979</ArticleId><ArticleId IdType="pubmed">29746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski SA, Midgley CM, Rha B, et al. Enterovirus D68–associated acute respiratory illness—new vaccine surveillance network, United States, July–October, 2017 and 2018. MMWR Morb Mortal Wkly Rep 2019;68:277–80. 10.15585/mmwr.mm6812a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6812a1</ArticleId><ArticleId IdType="pmc">PMC6448985</ArticleId><ArticleId IdType="pubmed">30921299</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021. MMWR Morb Mortal Wkly Rep 2021;70:1013–9. 10.15585/mmwr.mm7029a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Pons-Salort M, Messacar K, et al. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med 2021;13:eabd2400. 10.1126/scitranslmed.abd2400</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2400</ArticleId><ArticleId IdType="pubmed">33692131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd S, Yee E, English R, et al. National surveillance for acute flaccid myelitis—United States, 2018–2020. MMWR Morb Mortal Wkly Rep 2021;70:1534–8. 10.15585/mmwr.mm7044a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7044a2</ArticleId><ArticleId IdType="pmc">PMC8568096</ArticleId><ArticleId IdType="pubmed">34735423</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwane MK, Chaves SS, Szilagyi PG, et al. Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties—2002–2009. Am J Epidemiol 2013;177:656–65. 10.1093/aje/kws299</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws299</ArticleId><ArticleId IdType="pubmed">23436899</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggs HM, McNeal M, Nix WA, et al. Enterovirus D68 infection among children with medically attended acute respiratory illness, Cincinnati, Ohio, July–October 2014. Clin Infect Dis 2017;65:315–23. 10.1093/cid/cix314</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix314</ArticleId><ArticleId IdType="pmc">PMC5708293</ArticleId><ArticleId IdType="pubmed">28379349</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>